Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BAY
BAYER AG SPONS ADR
BAY
|
+$535M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$124M |
| 3 |
Banco Bradesco
BBD
|
+$98.1M |
| 4 |
Itaú Unibanco
ITUB
|
+$94.1M |
| 5 |
FIHD
UBS AG FI Enhanced Global High Yield ETN
FIHD
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PRXL
Parexel International Corp
PRXL
|
+$184M |
| 2 |
IRY
SPDR S&P International Health Care Sector
IRY
|
+$143M |
| 3 |
DFT
DuPont Fabros Technology Inc.
DFT
|
+$72.5M |
| 4 |
PNC Financial Services
PNC
|
+$31M |
| 5 |
HDFC Bank
HDB
|
+$26.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.92% |
| 2 | Technology | 13.57% |
| 3 | Healthcare | 12.73% |
| 4 | Consumer Discretionary | 8.41% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
476
DELISTED
Allergan plc
AGN
| $1.44M | ﹤0.01% |
7,015
+1,701
| +32% | +$396K |
|
|
EGRX
477
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.43M | ﹤0.01% |
23,921
+12,876
| +117% | +$779K |
|
478
Prothena Corp
PRTA
$425M
| $1.41M | ﹤0.01% |
21,813
-9
| -0% | -$551 |
|
479
Ericsson
ERIC
$32.2B
| $1.41M | ﹤0.01% |
245,459
+3,691
| +2% | +$22.8K |
|
480
Williams-Sonoma
WSM
$26.9B
| $1.4M | ﹤0.01% |
56,316
-1,336
| -2% | -$31.1K |
|
481
Lockheed Martin
LMT
$134B
| $1.4M | ﹤0.01% |
4,512
+627
| +16% | +$187K |
|
482
Berkshire Hathaway Class A
BRK.A
$1.1T
| $1.37M | ﹤0.01% |
5
-1
| -17% | -$265K |
|
483
ResMed
RMD
$30.6B
| $1.34M | ﹤0.01% |
17,450
-3,500
| -17% | -$268K |
|
484
TechnipFMC
FTI
$28.6B
| $1.34M | ﹤0.01% |
64,333
-1,664
| -3% | -$33.4K |
|
485
Korn Ferry
KFY
$4.18B
| $1.31M | ﹤0.01% |
+33,362
| New | +$1.15M |
|
486
iShares Global Financials ETF
IXG
$678M
| $1.31M | ﹤0.01% |
19,675
| – | – |
|
|
SPLK
487
DELISTED
Splunk Inc
SPLK
| $1.29M | ﹤0.01% |
19,434
-3,471
| -15% | -$217K |
|
488
Builders FirstSource
BLDR
$7.15B
| $1.29M | ﹤0.01% |
+71,717
| New | +$1.16M |
|
489
MakeMyTrip
MMYT
$5.36B
| $1.29M | ﹤0.01% |
44,832
| – | – |
|
|
INN
490
Summit Hotel Properties
INN
$746M
| $1.28M | ﹤0.01% |
80,059
| – | – |
|
491
Trane Technologies
TT
$101B
| $1.26M | ﹤0.01% |
14,108
+1,648
| +13% | +$146K |
|
492
UnitedHealth
UNH
$376B
| $1.21M | ﹤0.01% |
6,171
-1,528
| -20% | -$295K |
|
493
McDonald's
MCD
$192B
| $1.16M | ﹤0.01% |
7,410
+504
| +7% | +$79K |
|
494
Galicia Financial Group
GGAL
$7.99B
| $1.15M | ﹤0.01% |
22,311
+2,547
| +13% | +$109K |
|
495
Banco Macro
BMA
$5.88B
| $1.14M | ﹤0.01% |
9,679
+1,137
| +13% | +$110K |
|
|
QTS
496
DELISTED
QTS REALTY TRUST, INC.
QTS
| $1.13M | ﹤0.01% |
+21,575
| New | +$1.15M |
|
497
SPDR Gold Trust
GLD
$131B
| $1.11M | ﹤0.01% |
+9,105
| New | +$1.11M |
|
|
TWX
498
DELISTED
Time Warner Inc
TWX
| $1.11M | ﹤0.01% |
10,792
+626
| +6% | +$63.5K |
|
|
CNCE
499
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.1M | ﹤0.01% |
74,839
| – | – |
|
500
Mercado Libre
MELI
$95.2B
| $1.09M | ﹤0.01% |
4,228
+494
| +13% | +$131K |
|
Similar funds
Ken Fisher's Q3 2017 Portfolio in Review
As of Q3 2017, Ken Fisher held 922 positions worth $71.3B, up 7.5% from $66.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Fisher's Q3 2017 filing shows 120 new, 343 increased, 284 reduced and 79 closed positions. Its largest new stake was Coresite Realty Corporation: 286,849 shares worth $32.1M. The largest sale was Parexel International Corp, an estimated $184M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.
- Ken Fisher's largest Q3 2017 buy was Coresite Realty Corporation: 286,849 shares worth $32.1M.
- Ken Fisher added most to BAYER AG SPONS ADR in Q3 2017, an estimated $535M increase.
- Ken Fisher's biggest Q3 2017 reduction was PNC Financial Services, cutting an estimated $31M.
- Ken Fisher fully exited Parexel International Corp in Q3 2017, selling an estimated $184M.
- Ken Fisher's ten largest holdings make up 23% of its $71.3B portfolio in Q3 2017.
- Ken Fisher opened 120 new positions and closed 79 in Q3 2017.
- Ken Fisher's portfolio value rose 7.5% quarter-over-quarter to $71.3B.
Based on Fisher Asset Management's 13F filing for Q3 2017, filed 17 Oct 2017.